Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Communities & Collections
  • All of DSpace
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Chen, Henian"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • No Thumbnail Available
    Item
    How big is a big hazard ratio in clinical trials?
    (2023-09) Lu, Yuanyuan; Cen, Weiliang; Wang, Wei; Huang, Yangxin; Chen, Henian
    Background: Thehazardratio(HR)hasbeenwidelyusedasanindexofeffectsizeinclinicaltrialsfortime-to-eventdata.TheuseoftheCoxproportionalhazardsmodelsandotherhazardcenteredmodelsisubiquitousinclinicaltrialsfortime-to-eventdata.Therelativityofeffectsizes(small,medium,large)hasbeenwidelydiscussedandacceptedwhencomparingmagnitudeofassociationforcontinuousandcategoricaldata,butnotyetfortime-to-eventoutcomes.Methods: We review published hazard ratios, investigate the relationships among HR, relative risk (RR), odds ratio (OR), and Cohen’s d, and calculate the corresponding HRs for given event rate in control group (??0) by adding standard normal deviation with 0.2 (small), 0.5 (medium) and 0.8 (large) to the event rate in the case group (??1)based on equation ??1=1?(1???0)????.Results: OurresultsindicatethatHRsarefrom1.68to1.16whentheeventrateofcontrolgroupmovesfrom1%to90%,whichareequivalenttoCohen’sd=0.2(small).HRsarerangedbetween3.43and1.43whentheeventrateofcontrolgroupmovesfrom1%to90%,whichareequivalenttoCohen’sd=0.5(medium),HRsarevaluedbetween6.52and1.73whentheeventrateofcontrolgroupmovesfrom1%to90%,whichareequivalenttoCohen’sd=0.8(large).Conclusions: This study provides general guidelines in interpreting the magnitudes of HRs for time-to-event data in clinical trials

IMSEAR is the collaborative product of Health Literature, Library and Information Services (HELLIS) Network Member Libraries in the WHO South-East Asia Region.
HELLIS is coordinated by WHO Regional Office for South-East Asia.

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback